ClinConnect ClinConnect Logo
Search / Trial NCT04212520

Predictive Value of Non-fasting Blood Lipid Levels for Cardiovascular Events in Community Population(PICC Study)

Launched by GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL · Dec 24, 2019

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Non Fasting Lipid Cardiovascular And Cerebrovascular Events Major Adverse Cardiovascular Events

ClinConnect Summary

The PICC Study is researching how non-fasting blood lipid levels—like cholesterol and fats in the blood—can predict heart and brain health issues in people living in Chinese communities. Previous studies have shown a link between these lipid levels and serious health events, but researchers want to see if this is true for the Chinese population specifically.

To participate in this study, you need to be at least 18 years old, able to give your consent, and expected to live for more than a year. If you have a mental disorder, are unwilling to join, or have other health conditions that might interfere, you won't be eligible. As a participant, you'll help researchers understand how your non-fasting blood lipid levels relate to your cardiovascular health, which could help improve health outcomes in the future. The study is currently looking for volunteers, so if you meet the criteria, you might consider getting involved!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • •≥18 years old;
  • Signed informed consent;
  • Life expectancy is greater than 1 year.
  • Exclusion Criteria:
  • mental disorder;
  • is not willing to participate in the clinical study;
  • suffered with other disease to quite the trial;
  • violated the protocol.

About Guangdong Provincial People's Hospital

Guangdong Provincial People's Hospital is a leading tertiary healthcare institution located in Guangdong Province, China, renowned for its comprehensive medical services and advanced research capabilities. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical science through innovative research and the rigorous evaluation of new therapies and interventions. With a multidisciplinary team of experienced clinicians and researchers, the institution prioritizes patient safety and ethical standards while fostering collaborations with academic and industry partners to enhance healthcare outcomes and contribute to the global medical community.

Locations

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Trial Officials

Feng Ying-qing, PhD

Study Chair

Guangdong Provincial People's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials